Clin2
NCT07635914Possibly a fitNot yet recruiting

Aprocitentan for hard-to-control high blood pressure

Resistant Hypertension

Part of Heart & circulation clinical trials.

This trial tests a new medication called aprocitentan as an add-on treatment for people whose high blood pressure remains elevated despite taking three or more blood pressure medications. The goal is to see if adding this new drug can lower blood pressure further and be safe to use.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
382 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Age 18 or older
  • Already taking 3 or more blood pressure medications from different classes, at stable doses, for at least 4 weeks
  • Blood pressure still elevated (systolic ≥140 mmHg) despite medications
  • No recent stroke, heart attack, or unstable chest pain in the past 12 months
  • No severe kidney disease, liver problems, or heart rhythm abnormalities
  • Able to take study medication consistently and use effective birth control if applicable

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06282107Not yet recruiting
Testing a new approach for resistant hypertension

This study tests a treatment called BiSAAE for people whose high blood pressure doesn't improve with three standard medicines. The goal is to see if it is safe and helps lower blood pressure better.

NCT07708441Not yet recruiting· Phase 2/Phase 3
Testing a new pill for hard-to-treat high blood pressure

This trial tests a new medication (HRS-1780) for people whose high blood pressure is not well controlled, even with current treatments. It may help lower blood pressure effectively.

Chongqing, Chongqing Municipality
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07352969Not yet recruiting· Phase 2
Testing a new hypertension drug in mild to moderate patients

This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.

Beijing, Beijing Municipality
NCT07259733Recruiting
Fast control of tough high blood pressure in public clinics

This study tests a fast way to get high blood pressure under control faster for people whose current pills aren't working well enough. It focuses on people who have trouble taking all their medicine as directed (like missing doses).

São Paulo, São Paulo
NCT07758634Recruiting· Phase 1/Phase 2
Study of an experimental treatment for high blood pressure

This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.

Port Orange, Florida

Hear when a new Resistant Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.